Results 101 to 110 of about 276,420 (304)

Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler, Vivian Maas, Arian Taheri Amin, Jennifer Faber, Tamara Schaprian, Katharina Hill, Matthis Synofzik, Lisa H. Graf, Heike Jacobi, Manuela Lima, Ana F. Ferreira, Bart P. van de Warrenburg, Ilse H. J. Willemse, Dagmar Timmann, Andreas Thieme, Paola Giunti, Hector Garcia‐Moreno, Magda M. Santana, Jeannette Hübener‐Schmid, Elin H. Davies, Thomas Klockgether   +20 more
wiley   +1 more source

CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang, Yujie Liu, Fei Li, Xuelin Li, Lanlan Li, Jie Zhang, Yali Xu   +6 more
wiley   +1 more source

Translation and Validation of Rating-of-Fatigue Scale to be Used in Nonsurgical Endodontic Re-treatment

Journal of Pharmacy and Bioallied Sciences
Background: This study aimed to translate and validate the rating-of-fatigue (ROF) scale in the Kannada language. Methods: This current study involved two steps, where forward translation, backward translation, cross-cultural adaptation, and test of a ...
Chawre Mustufa, Huwaina Abd Ghani, Moksha Nayak, Mohd Fadhli Khamis, Zaihan Ariffin, Normastura Abd Rahman   +5 more
doaj   +1 more source

An objective, sensitive and ecologically valid neural measure of rapid human individual face recognition

, 2019
Friederike G. S. Zimmermann, Xiaoqian Yan, Bruno Rossion   +2 more
openalex   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source

Content and Face Validity of the Evaluation Tool of Health Information for Consumers (ETHIC): Getting Health Information Accessible to Patients and Citizens. [PDF]

Healthcare (Basel), 2023
Cocchi S, Cipolat Mis C, Mazzocut M, Barbieri I, Bassi MC, Cavuto S, Di Leo S, Miraglia Raineri A, Cafaro V, Ethic Validation Group.   +9 more
europepmc   +1 more source

OR fire virtual training simulator: design and face validity

, 2016
Denis Dorozhkin, Jaisa Olasky, Daniel B. Jones, Steven D. Schwaitzberg, Stephanie B. Jones, Caroline G. L. Cao, Marcos Molina, Steven M. Henriques, Jinling Wang, J. T. Flinn, Suvranu De   +10 more
openalex   +2 more sources

The Arabic Version of the Faces Pain Scale-Revised: Cultural Adaptation, Validity, and Reliability Properties When Used with Children and Adolescents [PDF]

, 2021
Jessica Finianos, Elisabet Sánchez‐Rodríguez, Jordi Miró   +2 more
openalex   +1 more source

Lived and Care Experiences of Chronic Musculoskeletal Shoulder Pain in Australian Adults: A Qualitative Study

Arthritis Care &Research, EarlyView.
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli, Joanne E. Jordan, Ilana N. Ackerman, Alison Thorpe, Jennifer G. Persaud, Linda J. Woodhouse, Jason Chua, Ben Horgan, Andrew M. Briggs   +8 more
wiley   +1 more source

Initial development of a patient-reported outcome measure of experience with cognitive impairment associated with schizophrenia

Patient Related Outcome Measures, 2017
Lisa C Welch,1 Jeremiah J Trudeau,2 Steven M Silverstein,3 Michael Sand,4 David C Henderson,5 Raymond C Rosen6 1Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, MA, 2Health Economics and Outcomes Research, Boehringer ...
Welch LC, Trudeau JJ, Silverstein SM, Sand M, Henderson DC, Rosen RC   +5 more
doaj